📗 Cite This Artifact
DARS2 Protein
DARS2 Protein (Aspartyl-tRNA Synthetase 2, Mitochondrial)
Overview
DARS2 (Aspartyl-tRNA Synthetase 2, Mitochondrial) is a critical mitochondrial aminoacyl-tRNA synthetase that plays an essential role in mitochondrial protein synthesis. This enzyme is responsible for the ATP-dependent attachment of aspartic acid to its cognate mitochondrial tRNA (tRNA^Asp), which is fundamental for the translation of all 13 mitochondrial-encoded proteins [1](https://pubmed.ncbi.nlm.nih.gov/21889355/). DARS2 is encoded by the DARS2 gene located on chromosome 12q24.1 and is ubiquitously expressed with highest levels in tissues with high mitochondrial demand, including the brain, heart, and skeletal muscle [2](https://pubmed.ncbi.nlm.nih.gov/22550328/). [@perez2018]
DARS2 Protein (Aspartyl-tRNA Synthetase 2, Mitochondrial)
Overview
DARS2 (Aspartyl-tRNA Synthetase 2, Mitochondrial) is a critical mitochondrial aminoacyl-tRNA synthetase that plays an essential role in mitochondrial protein synthesis. This enzyme is responsible for the ATP-dependent attachment of aspartic acid to its cognate mitochondrial tRNA (tRNA^Asp), which is fundamental for the translation of all 13 mitochondrial-encoded proteins [1](https://pubmed.ncbi.nlm.nih.gov/21889355/). DARS2 is encoded by the DARS2 gene located on chromosome 12q24.1 and is ubiquitously expressed with highest levels in tissues with high mitochondrial demand, including the brain, heart, and skeletal muscle [2](https://pubmed.ncbi.nlm.nih.gov/22550328/). [@perez2018]
The mitochondrial genetic system is distinct from the cytosolic translation machinery, requiring specialized components including mitochondrial aminoacyl-tRNA synthetases (mtaaRSs). DARS2 belongs to this unique family of enzymes that have evolved to function within the mitochondrial matrix and accurately translate the mitochondrial genome [3](https://pubmed.ncbi.nlm.nih.gov/23283301/). [@ramon2014]
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2">DARS2 Protein</th></tr>
<tr><td>Protein Name</td><td>Aspartyl-tRNA Synthetase 2, Mitochondrial</td></tr>
<tr><td>Gene</td><td>[DARS2](/genes/dars2)</td></tr>
<tr><td>UniProt</td><td>[Q9NXE1](https://www.uniprot.org/uniprot/Q9NXE1)</td></tr>
<tr><td>Location</td><td>Mitochondria (matrix)</td></tr>
<tr><td>Function</td><td>Mitochondrial tRNA aminoacylation</td></tr>
<tr><td>MW</td><td>73.8 kDa</td></tr>
<tr><td>Structure</td><td>Homodimer</td></tr>
<tr><td>Enzyme Class</td><td>EC 6.1.1.12</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">7 edges</a></td>
</tr>
</table>
</div>
Structure and Molecular Mechanism
DARS2 belongs to the class II aminoacyl-tRNA synthetase family and possesses the characteristic catalytic domain found in these enzymes. Unlike their cytosolic counterparts, mitochondrial aminoacyl-tRNA synthetases have evolved unique features to function within the mitochondrial environment and recognize mitochondrial tRNAs [4](https://pubmed.ncbi.nlm.nih.gov/23625846/).
Protein Domains
The protein contains several functional domains:
- Motif 1: ATP binding
- Motif 2: Amino acid binding
- Motif 3: tRNA 3'-end binding
Catalytic Mechanism
The aminoacylation reaction proceeds through a well-characterized two-step mechanism:
Step 1: Aminoacyl-adenylate formation
Aspartic acid + ATP → Asp-AMP + PPi
Step 2: tRNA Charging
Asp-AMP + tRNA^Asp → Asp-tRNA^Asp + AMP
This reaction is essential for mitochondrial translation, as the mitochondrial genetic system requires properly charged tRNAs for accurate protein synthesis. The reaction is driven forward by pyrophosphate hydrolysis [5](https://pubmed.ncbi.nlm.nih.gov/23283301/).
Role in Mitochondrial Function and Oxidative Phosphorylation
Mitochondria are essential for cellular energy production through oxidative phosphorylation (OXPHOS). The mitochondrial genome encodes 13 subunits of the electron transport chain complexes, along with 22 tRNAs and 2 rRNAs required for their translation [6](https://pubmed.ncbi.nlm.nih.gov/22100925/). DARS2-mediated mitochondrial translation is therefore crucial for:
- Complex I (NADH:ubiquinone oxidoreductase) - 7 mitochondrial-encoded subunits (MT-ND1-6, MT-ND4L)
- Complex III (Cytochrome bc1 complex) - 1 mitochondrial-encoded subunit (MT-CYB)
- Complex IV (Cytochrome c oxidase) - 3 mitochondrial-encoded subunits (MT-CO1-3)
- Complex V (ATP synthase) - 2 mitochondrial-encoded subunits (MT-ATP6, MT-ATP8)
Proper assembly of these complexes requires accurate mitochondrial translation, making DARS2 essential for maintaining cellular energy homeostasis. Each OXPHOS complex requires precise coordination between mitochondrial and nuclear-encoded proteins, with mitochondrial translation serving as a critical bottleneck [7](https://pubmed.ncbi.nlm.nih.gov/25920554/).
Clinical Implications and Disease Associations
Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL)
Biallelic mutations in DARS2 cause a recessive disorder characterized by childhood-onset progressive leukoencephalopathy. This devastating neurological condition was first described in 2007 and is characterized by [8](https://pubmed.ncbi.nlm.nih.gov/17377065/):
- Cerebellar ataxia - Progressive loss of coordination
- Spasticity - Muscle stiffness and rigidity
- Intellectual disability - Cognitive decline
- Brainstem dysfunction - Cranial nerve involvement
- Elevated cerebrospinal fluid lactate - Metabolic dysfunction
- White matter abnormalities - MRI findings
The most common mutation is a splice-site mutation (c.454-3C>G) that reduces DARS2 activity to ~20-30% of normal. Genotype-phenotype correlations show that residual enzyme activity correlates with disease severity [9](https://pubmed.ncbi.nlm.nih.gov/21889355/).
Amyotrophic Lateral Sclerosis (ALS)
Recent studies have identified DARS2 mutations as a risk factor for ALS, particularly in sporadic cases. The mechanism involves multiple pathways [10](https://pubmed.ncbi.nlm.nih.gov/33449951/):
Alzheimer's Disease
While not directly causative, DARS2 dysfunction may contribute to Alzheimer's disease pathogenesis through multiple mechanisms [11](https://pubmed.ncbi.nlm.nih.gov/28715993/):
- Mitochondrial bioenergetic deficits - Reduced ATP production
- Impaired amyloid-beta metabolism - Altered APP processing
- Synaptic energy failure - Calcium dysregulation
- Increased neuronal vulnerability - Reduced resilience to stress
- Accelerated aging - Metabolic decline
Parkinson's Disease
In PD, DARS2 may play a protective role:
- Mitochondrial complex I deficiency in dopaminergic neurons
- PINK1/PARKIN mitophagy pathway interactions
- Alpha-synuclein toxicity modulation
- LRRK2 pathway crosstalk [12](https://pubmed.ncbi.nlm.nih.gov/26000515/)
Therapeutic Implications and Drug Development
Targeting DARS2 and mitochondrial translation represents a promising therapeutic approach for neurodegenerative diseases:
Small Molecule Enhancers
Compounds that improve mitochondrial translation efficiency:
- Elamipretide (SS-31) - Mitochondrial-targeted peptide
- CoQ10 analogs - Electron transport chain support
- Riboflavin - Mitochondrial cofactor precursor
Gene Therapy Approaches
AAV-mediated delivery of functional DARS2:
- Tissue-specific promoters
- Self-complementary vectors
- miRNA silencing of mutant alleles
Mitochondrial Protectants
Agents that preserve mitochondrial function:
- Metformin - AMPK activation
- Nicotinamide riboside - NAD+ precursor
- PQQ - Mitochondrial biogenesis
Metabolic Modulators
Compounds that enhance alternative energy pathways:
- Ketogenic diet considerations
- Glutamine metabolism targeting
- Anaplerotic agents
Protein-Protein Interactions Network
DARS2 interacts with several proteins involved in mitochondrial function:
| Partner Protein | Interaction Type | Functional Significance |
|-----------------|------------------|------------------------|
| Mitochondrial ribosome | Direct binding | tRNA channeling to ribosome |
| EF-Tu (TUFM) | Direct binding | tRNA delivery to ribosome |
| LRPPRC | Indirect | mRNA stabilization in mitochondria |
| CLPX | Direct binding | Quality control and turnover |
| Mitochondrial Hsp60 | Chaperone | Protein folding assistance |
| p32 (C1QBP) | RNA binding | Mitochondrial RNA metabolism |
Research Directions and Future Perspectives
Current research areas include:
See Also
- [Mitochondrial Diseases](/diseases/mitochondrial-diseases)
- [Leukodystrophy](/diseases/leukodystrophy)
- [ALS Gene Therapy](/therapeutics/als-gene-therapy)
- [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics)
- [Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress)
- [Mitochondrial Protein Synthesis](/mechanisms/mitochondrial-protein-synthesis)
- [OXPHOS Complexes](/proteins/oxphos-complexes)
- [Motor Neuron Disease](/diseases/motor-neuron-disease)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | proteins-dars2 |
| kg_node_id | DARS2 |
| entity_type | protein |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-4737d3643725 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-dars2'} |
| _schema_version | 1 |
cites (1)
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-proteins-dars2?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[DARS2 Protein](http://scidex.ai/artifact/wiki-proteins-dars2)
http://scidex.ai/artifact/wiki-proteins-dars2